AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from the US Food and Drug Administration (FDA) for an expanded indication of ...

Stay up-to-date with the latest and best audio content from CBC Listen delivered to your inbox every two weeks.

incisive interviews with politicians across the political spectrum and newsmakers and commentators from Aotearoa and around the world. There's a lot to talk about in the mornings and Morning Report is ...